2014-02-03 06:56:27 - Rudolf Jaenisch, MIT to Keynote Present at the Stem Cell Summit – Apr 23-25, 2014 in Cambridge, MA
Rudolf Jaenisch, founding member of the Whitehead Institute and professor of biology at the Massachusetts Institute of Technology will give a plenary keynote presentation the Stem Cell Summit 2014 to be held on April 23-25, 2014 in Cambridge, MA.
Rudolf Jaenisch is a pioneer of transgenic science, in which an animal’s genetic makeup is altered. He has focused on creating transgenic mice to study cancer and neurological diseases. Jaenisch’s first breakthrough occurred in 1974 when he and Beatrice Mintz showed that foreign DNA could be integrated into the DNA of early mouse embryos. They injected retrovirus into early mouse embryos and showed that leukemia DNA sequences had integrated the mouse genome and also to its offspring. These mice were the
first transgenic mammals in history.
Dr. Jaenisch will join other top experts from academia, industry and government to discuss recent developments in stem cell research. Experts will discuss pre-clinical and clinical trials of stem cell therapy, regenerative medicine, tissue engineering, cancer stem cells, stem cell reprogramming, new paradigms for drug discovery/cell therapy and regulatory policies. Experts will also discuss other important stem cell issues such business opportunities, challenges in commercialization and the potential strategies for overcoming these challenges. What categories of companies are currently commercially viable? How are they being funded? What kind of strategic relationships are available within the industry?
In its 11th year, the Stem Cell Summit 2014 includes two parallel conferences including joint sessions. This summit provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and commercialization of stem cells.
Conference A: Stem Cell Research & Regenerative Medicine:
Advances in Adult & Pluripotent Stem Cells
New Paradigms in Cell Therapy
Cells for Drug Discovery & Diagnostics
Conference B: Stem Cell Commercialization & Partnering:
Novel Technologies in Stem Cell Research
Overcoming Challenges in Clinical Development
Commercialization: Bringing Therapeutics to Market
Panel Discussion: Strategic Partnering
Joint Sessions: (Conference A+B)
Applications of Regulatory guidance in Advancing Cell Therapy
For more information, please visit www.gtcbio.com/stemcellsummit